STRYKER NEUROVASCULAR-UTAH-SALT LAKE CITY UNKNOWN_NEUROVASCULAR_PRODUCT; CATHETER, PERCUTANEOUS
|
Back to Search Results |
|
Catalog Number UNK_NEU |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Stroke/CVA (1770); Hematoma (1884); Intracranial Hemorrhage (1891); Perforation (2001); Pseudoaneurysm (2605); Thromboembolism (2654); Vascular Dissection (3160); Embolism/Embolus (4438)
|
Event Date 02/07/2023 |
Event Type
Injury
|
Event Description
|
It was reported during a post-market clinical follow-up (pmcf) double blind survey for the subject flowgate2® balloon guide catheter, 8f x 95cm, the following adverse events were observed; access site complications (pseudoaneurysm or hematoma), distal emboli, mortality, headaches, unknown other adverse event, spasm, problems with bgc (leak or kinking), stroke, symptomatic intracranial hemorrhage, thromboembolic event, vessel cutoff downstream, vessel dissection perforation as per the responses received.No further information is available.
|
|
Manufacturer Narrative
|
H3 other text : the device is not available to the manufacturer.
|
|
Manufacturer Narrative
|
Although the dhr (device history record) could not be reviewed because the lot number remains unknown, there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.It was reported during a post-market clinical follow-up (pmcf) survey was conducted for stryker flowgate2® balloon guide catheter device #¿s (1) (b)(6) in france, germany, italy, spain and united states that in one case a number of patient complications were noted: patient embolus, patient thromboembolic event, patient intracranial hemorrhage, patient stroke, patient vessel dissection, patient vessel perforation, patient hematoma, and patient pseudoaneurysm.The patients' outcome was unknown.The risk of the above reported list of patient harms is documented in the flowgate device directions for use (dfu), as a potential adverse event which can occur as a result of these type of procedures.Also based upon medical review, the harms observed in these complaints are anticipated in nature as per the device risk assessment.There was no indication of device malfunction or failure, therefore an assignable cause of anticipated procedural complication, will be assigned to the reported events.
|
|
Event Description
|
Post-market clinical follow-up (pmcf) anonymous survey was conducted for subject flowgate2® balloon guide catheter.The survey was conducted in france, germany, italy, spain and united states.During the survey, distal emboli, symptomatic intracranial hemorrhage, stroke, vessel dissection perforation, thromboembolic event, access site complications (pseudoaneurysm or hematoma) and an unknown other adverse event were reported to have occurred as per the responses received.Medical intervention was required.No other information is available about the events reported in the survey.
|
|
Search Alerts/Recalls
|
|
|